allergic rhinitis


The purpose of the study was to identify the prevalence of allergic rhinitis (AR) symptoms in children of Kharkiv city and to establish the dynamics of symptoms since 1998. The study is phase IV of the international ISAAC program. It was conducted in 2015-2017. 5735 children were interviewed, including 3238 children aged 6-7 years old and 2197 children aged 13-14 years old. The incidence of non-cold-related sneezing was found in 14.7 % and 16.1 %, respectively; during the past 12 months similar problems with nose breathing were noted in 9.1 % and 9.9 %; accompanied by conjunctivitis – in 3.4 % and 4.8 % of children 6-7 and 13-14 years, respectively. Most patients had seasonal exacerbations and mild / moderate rhinitis. The AR diagnosis was verified in 12.2 % and 11.3 % of children, respectively. The decreasing of AR symptoms prevalence was found in children of all ages. The dynamics of the AR symptoms prevalence, "eye" symptoms over the past 20 years show a probable decrease in all indicators, which can be explained by the widespread introduction in medical practice of screening methods for the disease diagnosing, activation of primary and secondary prevention.


Kef K, Güven S. The Prevalence of Allergic Rhinitis and Associated Risk Factors Among University Students in Anatolia. J Asthma Allergy. 2020;13:589-597. Published 2020 Nov 10. doi:10.2147/JAA.S279916

Öçal R., Bayar Muluk N., Mullol J. (2020) Epidemiology of Allergic Rhinitis. In: Cingi C., Bayar Muluk N. (eds) All Around the Nose. Springer, Cham.

Wise, S. K., Lin, S. Y., & Toskala, E. (2018). International consensus statement on allergy and rhinology: Allergic rhinitis—executive summary. International Forum of Allergy & Rhinology, 8(2), 85-107. doi:10.1002/alr.22070

Bousquet, J., Anto, J. M., Bachert, C., Baiardini, I., Bosnic-Anticevich, S., Canonica, G. W., . . . Toppila-Salmi, S. (2020). Allergic rhinitis. Nature Reviews Disease Primers, 6(1). doi:10.1038/s41572-020-00227-0

Myers, J. M., Schauberger, E., He, H., Martin, L. J., Kroner, J., Hill, G. M., . . . Hershey, G. K. (2019). A Pediatric Asthma Risk Score to better predict asthma development in young children. Journal of Allergy and Clinical Immunology, 143(5). doi:10.1016/j.jaci.2018.09.037.

Shine, S., Muhamud, S., & Demelash, A. (2019). Prevalence and associated factors of bronchial asthma among adult patients in Debre Berhan Referral Hospital, Ethiopia 2018: A cross-sectional study. BMC Research Notes, 12(1). doi:10.1186/s13104-019-4670-9

Stenberg, K., Lauer, J. A., Gkountouras, G., Fitzpatrick, C., & Stanciole, A. (2018). Econometric estimation of WHO-CHOICE country-specific costs for inpatient and outpatient health service delivery. Cost Effectiveness and Resource Allocation, 16(1). doi:10.1186/s12962-018-0095-x

Fasola, S., Montalbano, L., Ferrante, G., Cilluffo, G., Malizia, V., Baiardini, I., . . . Grutta, S. L. (2020). RAPP‐children: A new tool for assessing quality of life in patients with asthma and rhinitis. Clinical & Experimental Allergy, 50(6), 662-671. doi:10.1111/cea.13599

Sanz‐Santiago, V., Diez‐Vega, I., Santana‐Sosa, E., Nuevo, C. L., Ramirez, T. I., Vendrusculo, F. M., . . . Pérez‐Ruiz, M. (2020). Effect of a combined exercise program on physical fitness, lung function, and quality of life in patients with controlled asthma and exercise symptoms: A randomized controlled trial. Pediatric Pulmonology, 55(7), 1608-1616. doi:10.1002/ppul.24798

Baiardini, I., Fasola, S., Montalbano, L., Cilluffo, G., Malizia, V., Ferrante, G., . . . Grutta, S. L. (2016). RHINASTHMA-Children: A new quality of life tool for patients with respiratory allergy. Pediatric Allergy and Immunology, 28(1), 102-105. doi:10.1111/pai.12667

Azzano, P, Dufresne, É, Poder, T, Bégin, P. Economic considerations on the usage of biologics in the allergy clinic. Allergy. 2021; 76: 191– 209.

Boudewijn J.H. Dierick , Thys van der Molen , Bertine M. J. Flokstra-de Blok , Antonella Muraro , Maarten J. Postma , Janwillem W.H. Kocks & Job F.M. van Boven (2020) Burden and socioeconomics of asthma, allergic rhinitis, atopic dermatitis and food allergy, Expert Review of Pharmacoeconomics & Outcomes Research, 20:5, 437-453, DOI: 10.1080/14737167.2020.1819793

Mallol J, Crane J, von Mutius E, Odhiambo J, Keil U, Stewart A; ISAAC Phase Three Study Group. The International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three: a global synthesis. Allergol Immunopathol (Madr). 2013 Mar-Apr;41(2):73-85. doi: 10.1016/j.aller.2012.03.001. Epub 2012 Jul 6. PMID: 22771150.

Strachan, D., Pearce, N., Garcia-Marcos, L., Asher, I. (2017). International Study of Asthma and Allergies in Childhood, 1992-2005. [data collection]. UK Data Service. SN: 8131,

Огнев В. А. Эпидемиология астмы и аллергии у детей. По материалам международной программы по изучению астмы и аллергии у детей (International Study of Asthma and Allergies in Childhood (ISAAC)): монография / В. А. Огнев. – Харьков:Щедрасадиба плюс, 2015. – 336 c.

Клименко В.А., Карпушенко Ю.В., Кожина О.С. (2018) Результаты исследования IV фазы ISAAC (International Study of Asthma and Allergy in Childhood) в Харьковском регионе. Вестник ВГМУ, 17(6), 85-91. doi:

Лисицын Ю.П. Общественное здоровье и здравоохранение: учебник.– 2-е изд.– М.: ГЭОТАР-Медиа, 2010. — 512 с.

Sultész, M., Horváth, A., Molnár, D., Katona, G., Mezei, G., Hirschberg, A., & Gálffy, G. (2020). Prevalence of allergic rhinitis, related comorbidities and risk factors in schoolchildren. Allergy, Asthma & Clinical Immunology, 16(1). doi:10.1186/s13223-020-00495-1

Brożek, G., Jankowski, M., Jarosinska, A., Zejda, J., Kocot, K., Gawlewicz, J., . . . Nowak, B. (2019). Prevalence of asthma, respiratory symptoms and allergic diseases in children aged 6-9 in Katowice (Poland). Epidemiology. doi:10.1183/13993003.congress-2019.pa5071

Aberle, N. (2018). Allergic Diseases and Atopy among Schoolchildren in Eastern Croatia. Acta Clinica Croatica, 57(1), 82-90. doi:10.20471/acc.2018.57.01.09

Copyright for articles published in the journal is regulated by the License Agreement for the use of a scientific article in the journal, which is concluded between the author of the article (Licensor) and Kharkov National Medical University (Licensee, publisher of the journal "Inter Collegas"). The licensor grants to the Licensee a non-exclusive non-exclusive license for the use of the article (a license that does not exclude the use of the article by the Licensor and the issuance of licenses to others for use of this article) on the terms and for the period specified in the contract. The licensor (the author of the article) grants the Licensee the right to reproduce the article (publication in the journal "Inter Collegas", publication, duplication, duplication or other reproduction of the article without limiting the circulation of copies, each copy of the article must contain the name of the Licensor; Of general information, including the publication of the article in full or in part on the Internet on the journal page, the right to use the metadata of the article (titles, full names of authors, annotations, bibliography eskih materials) through the dissemination and communication to the public, processing and systematization, as well as inclusion in various databases and in-formational system).

The licensor grants the licensee the right to transfer, store and process his personal data (full name, scientific degree, academic title, place of work and position, contact information of the authors) with the purpose of including them in the database in accordance with the Law of Ukraine No. 2297 - VI "on protection of personal data" from 01.06.2010.

Personal data and metadata of the article are provided for their storage and processing in various databases and information systems, including them in analytical and statistical reporting, creating sound relationships between the objects of works of science, literature and art with personal data, etc. on unlimited territory. The licensee has the right to transfer the specified data for processing and storage to third parties provided that such a fact is notified with the provision of information about the third party (name and address) to the Licensor.